Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹7742 Cr.
Stock P/E
105.8
P/B
2.8
Current Price
₹224.6
Book Value
₹ 80.5
Face Value
10
52W High
₹284.9
52W Low
₹ 197
Dividend Yield
0%

Religare Enterprises Overview

Business

Religare Enterprises Ltd. (REL) is an India-based diversified financial services company. Its core operations primarily revolve around health insurance and broking services. The company aims to provide a comprehensive suite of financial solutions to retail, HNI, and institutional clients. It makes money primarily through insurance premiums from its health insurance arm (Care Health Insurance), and through brokerage fees, commissions, and advisory services from its broking and wealth management arm (Religare Broking Ltd.). It also has a non-banking financial company (NBFC) subsidiary (Religare Finvest Ltd. - RFL), which is currently undergoing resolution and has been a source of significant historical challenges.

Revenue Mix

Religare Enterprises Ltd. primarily operates through the following segments:

Care Health Insurance (CHI): This is the flagship and most profitable segment, offering health insurance products. It contributes the majority of the company's value and positive earnings.

Religare Broking Ltd.: Provides equity, commodity, and currency broking, depository services, and investment banking services to retail and institutional clients.

Religare Finvest Ltd. (RFL): An NBFC subsidiary. This segment has been under a corrective action plan by the Reserve Bank of India due to past financial irregularities and is undergoing resolution. Its contribution to current positive earnings is limited, and it represents a legacy issue being addressed.

Industry

Religare operates within the competitive Indian financial services sector.

Health Insurance: Care Health Insurance operates in a rapidly growing, but highly competitive, Indian health insurance market. It has established itself as a credible player with a significant market share among standalone health insurers, positioning it well to capitalize on increasing healthcare awareness and costs.

Broking: Religare Broking competes in a fragmented broking industry, facing intense competition from both traditional full-service brokers and new-age discount brokers. It leverages its legacy brand and distribution network to serve its client base.

Overall Positioning: Post its historic promoter issues and restructuring, Religare is now primarily seen as a holding company with a strong health insurance asset, while the broking business maintains a niche, and the NBFC is a legacy issue being resolved.

MOAT

Brand & Trust (Care Health Insurance): Care Health Insurance has built a recognized brand name and trust in the specialized health insurance segment, which is crucial for customer acquisition and retention in an emotional product category like health.

Regulatory Licenses: Ownership of critical financial licenses (insurance, broking, NBFC) provides a barrier to entry for new players, as these require significant capital, compliance, and regulatory approvals.

Distribution Network: REL benefits from an established distribution network for both its health insurance products and broking services across India, facilitating reach and customer acquisition.

Specialization: Care Health Insurance's focus purely on health insurance allows for specialized product development, underwriting expertise, and claims processing efficiency.

Growth Drivers

Rising Health Insurance Penetration: India's low health insurance penetration and increasing awareness of healthcare costs present a significant growth runway for Care Health Insurance.

Increasing Financialization of Savings: A growing economy and higher disposable incomes are driving more individuals to invest in capital markets, benefiting the broking business.

Digital Adoption: Increasing digital adoption in financial services can lead to wider reach, lower customer acquisition costs, and improved operational efficiency across segments.

Resolution of RFL Issues: A successful and timely resolution of the Religare Finvest Ltd. (RFL) legacy issues could remove a significant financial and reputational overhang, unlocking value and potentially freeing up capital.

Strategic Investor Interest: The ongoing interest from institutional investors and potential for new promoter/management control could bring in capital, strategic direction, and improved governance, driving future growth.

Risks

Regulatory & Legal Risks: The financial services industry is highly regulated. Changes in policies by IRDAI (for insurance), SEBI (for broking), and RBI (for NBFC) can impact profitability. Ongoing legal issues related to past promoter fraud and the RFL resolution pose significant risks.

Intense Competition: All segments (health insurance, broking) face fierce competition, which can put pressure on market share and margins.

Economic Downturn: A slowdown in the Indian economy could lead to lower investment activity (impacting broking) and potentially higher claims or lower premium growth in insurance.

Capital Adequacy: Maintaining adequate capital for its insurance and NBFC operations, especially given growth ambitions and past liabilities, is a continuous requirement.

Reputational Risk: The company has faced significant reputational challenges due to past promoter issues. Rebuilding trust and perception among investors and customers is a long-term endeavor.

Management & Ownership

Religare Enterprises Ltd. has undergone significant changes in its management and ownership structure. The original promoters, Malvinder Mohan Singh and Shivinder Mohan Singh, are no longer in control due to legal and financial issues. The company is currently managed by a professional board and management team working towards resolving legacy issues and focusing on core businesses. There is no single promoter group in the traditional sense. However, the Burman Family (promoters of Dabur India Ltd.) has been steadily increasing its stake and is a significant shareholder, indicating potential for a change in control and strategic direction.

Outlook

Religare Enterprises Ltd. presents a mixed outlook. The company's primary asset, Care Health Insurance, is well-positioned in a high-growth sector and continues to deliver strong performance, forming the core value driver. The broking business provides a steady, albeit competitive, revenue stream. The successful resolution of the long-standing issues surrounding Religare Finvest Ltd. (RFL) is critical to fully unlock value and eliminate a significant drag on the company's financial health and valuation. The increasing stake by the Burman Family suggests potential for renewed strategic focus, capital infusion, and improved governance, which could be a catalyst for future growth and a re-rating of the stock. However, the company continues to face inherent risks from intense competition, regulatory scrutiny, and the lingering complexities of its past legal and financial challenges. Its trajectory will largely depend on sustained execution, prudent management, and the timely resolution of legacy matters.

Religare Enterprises Share Price

Live · BSE / NSE · Inception: 1984
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Religare Enterprises Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Operating Revenue 1856 1710 1952 1668 2042 1872 2064 2056 2467 2353
Other Income 19 5 19 2 8 5 18 12 6 5
Total Income 1874 1714 1971 1670 2050 1876 2083 2068 2473 2358
Total Expenditure 1833 1653 1876 1730 1805 1851 2003 2151 2325 2402
Operating Profit 42 62 95 -60 245 26 79 -83 148 -44
Interest Expense 18 13 13 5 6 7 10 9 10 15
Depreciation 17 16 15 14 17 13 12 11 12 18
Profit Before Tax 236 33 67 -79 222 6 57 -103 127 -77
Provision for Tax 55 6 -1 -16 71 -2 12 -27 32 -30
Profit After Tax 181 27 69 -63 151 8 46 -77 96 -47
Adjustments -56 -9 -17 20 -52 -10 -7 31 -13 26
Profit After Adjustments 125 18 51 -43 98 -2 39 -45 82 -21
Adjusted Earnings Per Share 3.8 0.5 1.6 -1.3 3 -0.1 1.2 -1.4 2.5 -0.6

Religare Enterprises Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Operating Revenue 5659 4181 2524 2307 2366 2493 3224 4676 6235 7378 8459 8940
Other Income 71 69 211 94 42 58 165 504 718 192 201 41
Total Income 5730 4250 2736 2401 2408 2551 3389 5181 6952 7570 8660 8982
Total Expenditure 3280 2074 2842 3025 2352 2256 3616 4514 6551 7202 8473 8881
Operating Profit 2450 2176 -106 -624 56 294 -227 666 401 368 187 100
Interest Expense 1879 1840 1271 854 855 733 750 641 112 63 53 44
Depreciation 36 31 30 26 61 59 53 56 72 62 47 53
Profit Before Tax 282 -136 -1407 -1504 -1030 -497 -1031 3259 448 243 87 4
Provision for Tax 222 -13 -227 -3 8 -20 507 90 100 61 14 -13
Profit After Tax 60 -123 -1181 -1501 -1038 -478 -1539 3169 347 183 73 18
Adjustments -108 -51 136 214 106 -31 -5 -87 -115 -58 13 37
Profit After Adjustments -48 -174 -1045 -1287 -932 -508 -1544 3082 233 125 86 55
Adjusted Earnings Per Share -2.7 -9.8 -58.6 -59.3 -36.1 -19.6 -48.4 95.2 7.1 3.8 2.6 1.7

Religare Enterprises Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 3863 2753 1837 833 101 -47 -982 2058 2343 2515 2908
Minority's Interest 185 494 418 219 93 345 450 620 831 921 969
Borrowings 11858 8917 0 0 0 3878 3740 245 0 0 100
Current Liability 10304 8253 11607 7707 6940 3378 4386 2584 6146 7536 10324
Other Liabilities & Provisions 2216 1605 732 834 476 614 1714 2530 102 155 156
Total Liabilities 28427 22022 14594 9594 7611 8168 9308 8036 9423 11127 14457
Loans 13859 0 0 0 0 0 0 0 607 431 444
Investments 1775 1146 0 0 0 0 0 0 2867 7789 10024
Fixed Assets 1785 103 80 83 175 117 127 196 161 145 133
Other Loans 1306 1390 1905 1143 504 361 329 330 114 102 99
Other Non Current Assets 206 143 45 35 29 189 147 123 160 269 317
Current Assets 9496 19240 12564 8333 6903 7501 8705 7386 5514 2391 3441
Total Assets 28427 22022 14594 9594 7611 8168 9308 8036 9423 11127 14457

Religare Enterprises Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 1025 1222 1524 414 119 372 251 1717 205 201 254
Cash Flow from Operating Activities -2154 5871 5802 3555 2433 1373 1596 1506 1500 1523 1820
Cash Flow from Investing Activities 515 2318 -457 -31 -436 -1181 -689 -939 -1348 -1185 -2176
Cash Flow from Financing Activities 1853 -7696 -6455 -3819 -1743 -314 559 -2079 -156 -285 690
Net Cash Inflow / Outflow 214 492 -1110 -295 254 -122 1466 -1512 -4 53 334
Closing Cash & Cash Equivalent 1222 1546 414 119 372 251 1717 205 201 254 588

Religare Enterprises Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) -2.67 -9.77 -58.56 -59.33 -36.12 -19.6 -48.43 95.24 7.06 3.77 2.58
CEPS(Rs) 5.39 -5.18 -64.47 -68 -37.85 -16.15 -46.58 99.67 12.71 7.4 3.61
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 215.2 152.81 102.91 33.42 2.63 -2.66 -30.95 63.52 70.9 76.05 76.42
Net Profit Margin 1.07 -2.95 -46.76 -65.05 -43.87 -19.17 -47.73 67.76 5.57 2.48 0.86
Operating Margin 38.18 40.74 -5.42 -28.15 -7.39 9.45 -8.71 83.39 8.97 4.15 1.66
PBT Margin 4.98 -3.26 -55.75 -65.16 -43.53 -19.96 -31.98 69.68 7.18 3.3 1.03
ROA(%) 0.22 -0.49 -6.45 -12.41 -12.07 -6.06 -17.61 36.54 3.98 1.78 0.57
ROE(%) 1.56 -3.76 -51.76 -117.19 -261.78 0 0 592.99 15.82 7.53 2.89
ROCE(%) 9.72 8.16 -0.93 -6.72 -2.69 4.57 -6.46 117.45 20.44 11.46 4.71
Price/Earnings(x) 0 0 0 0 0 0 0 1.52 29.64 62.33 78.25
Price/Book(x) 1.33 1.42 0.53 0.88 7.21 -32.89 -4.21 2.28 2.95 3.09 2.64
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 4.17 4.02 3.63 2.63 1.85 2.58 2.04 0.99 0.99 0.93 0.64
EV/Core EBITDA(x) 9.64 7.73 -86.09 -9.72 78.08 21.85 -28.91 6.92 15.45 18.66 28.97
Interest Earned Growth(%) 3.32 -26.12 -39.62 -8.6 2.55 5.35 29.31 45.07 33.32 18.34 14.65
Net Profit Growth -81.22 -304.61 -856.97 -27.14 30.85 53.97 -221.99 305.95 -89.04 -47.4 -59.97
EPS Growth(%) -130.99 -265.68 -499.23 -1.32 39.12 45.74 -147.07 296.68 -92.58 -46.65 -31.49
Interest Coverage(x) % 1.15 0.93 -0.11 -0.76 -0.2 0.32 -0.37 6.08 5 4.88 2.64

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +15% +22% +28% +4%
Operating Profit CAGR -49% -35% -9% -23%
PAT CAGR -60% -72% — +2%
Share Price CAGR -11% -2% +5% -2%
ROE Average +3% +9% +124% +17%
ROCE Average +5% +12% +30% +15%

Religare Enterprises Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 30.56 %
FII 9.64 %
DII (MF + Insurance) 8.59 %
Public (retail) 51.21 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 000025.6725.8325.8326.2730.2730.56
FII 7.918.498.018.048.258.17.87.617.859.64
DII 8.1710.9913.4313.1311.7511.6110.269.328.518.59
Public 83.9280.5278.5678.8354.3354.4656.1156.853.3751.21
Others 0000000000
Total 100100100100100100100100100100

Religare Enterprises Peer Comparison

Finance - Investment Edit Columns

Religare Enterprises Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Religare Enterprises Pros & Cons

Pros

  • Company is almost debt free.

Cons

  • Promoter holding is low: 30.56%.
  • Company has a low return on equity of 9% over the last 3 years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp